Florian Clatot
Laboratoire National Henri Becquerel(FR)
Publications by Year
Research Areas
Cancer Immunotherapy and Biomarkers, Breast Cancer Treatment Studies, Cancer Genomics and Diagnostics, Cancer Cells and Metastasis, Head and Neck Cancer Studies
Most-Cited Works
- → Switch to fulvestrant and palbociclib versus no switch in advanced breast cancer with rising ESR1 mutation during aromatase inhibitor and palbociclib therapy (PADA-1): a randomised, open-label, multicentre, phase 3 trial(2022)291 cited
- → Cetuximab, docetaxel, and cisplatin versus platinum, fluorouracil, and cetuximab as first-line treatment in patients with recurrent or metastatic head and neck squamous-cell carcinoma (GORTEC 2014-01 TPExtreme): a multicentre, open-label, randomised, phase 2 trial(2021)218 cited
- → Sarcopenia is an independent prognostic factor in elderly patients with diffuse large B-cell lymphoma treated with immunochemotherapy(2013)154 cited
- → Prognostic impact of fat tissue loss and cachexia assessed by computed tomography scan in elderly patients with diffuse large B‐cell lymphoma treated with immunochemotherapy(2014)134 cited
- → Evolution of overall survival and receipt of new therapies by subtype among 20 446 metastatic breast cancer patients in the 2008-2017 ESME cohort(2021)127 cited
- → Debio 1143 and high-dose cisplatin chemoradiotherapy in high-risk locoregionally advanced squamous cell carcinoma of the head and neck: a double-blind, multicentre, randomised, phase 2 study(2020)126 cited
- → Diagnostic value of CA19.9, circulating tumour DNA and circulating tumour cells in patients with solid pancreatic tumours(2017)117 cited
- → A pan-cancer analysis of the human tumor coagulome and its link to the tumor immune microenvironment(2020)112 cited
- → Anti-Müllerian hormone as a marker of ovarian reserve and premature ovarian insufficiency in children and women with cancer: a systematic review(2022)107 cited
- → TERT Promoter Alterations in Glioblastoma: A Systematic Review(2021)97 cited